You are cordially invited to attend a virtual meeting co-sponsored by the NIAID, FDA, and BRADA. Due to Covid restrictions, we are hosting a hybrid meeting with a major virtual component. Speakers, moderators, and expert panelists will attend in-person, while all other attendees should sign up virtually through the Zoom registration link below.


Workshop Details

What: The Gastrointestinal Acute Radiation Syndrome Workshop

When: August 29th, 2022 (9am-4:30pm EDT) and August 30th, 2022 (9:00am-5:00pm EDT)

Where: Zoom (Registration Link Below)


Zoom Registration

Please register for the virtual event using the link below. You will receive an email confirmation with a personalized link to access the meeting - please do not share this personalized meeting link with anyone. If there are others who would like to join, please send the workshop organizers an email (care of: with the proposed attendee’s contact information.


Register in advance for this meeting using the link below:


CMCRC Annual Meeting

November 17-18, 2022

More details to come.


Register Today for the NIH Data Management and Sharing (DMS) Policy Webinar Series


The NIH Office of Science Policy (OSP) and the Office of Extramural Research (OER) invite you to join them for an informative webinar series focused on the new NIH Data Management and Sharing (DMS) Policy which goes into effect on January 25, 2023. This policy reinforces NIH’s longstanding commitment to making the research it funds available to the public and sets the baseline expectation that sharing data is a fundamental component of the research process.

Registration is now open for this 2-part series A Conversation with NIH: Implementing the New Data Management and Sharing Policy. In this series, our policy experts will break down what the policy means for you and discuss key factors to consider when sharing data. Don't miss this valuable opportunity to learn more about this policy and get your questions answered!

Registration is required separately for each webinar.

  • Thursday, August 11; 1:30 – 3:00 PM EST
    Understanding the New NIH Data Management and Sharing (DMS) Policy
    In this first webinar of the series, you will learn about DMS policy expectations, the applicability of the policy, how to prepare a Data Management and Sharing Plan, and considerations for sharing data responsibly.
    August 11 - Part 1 - DMS Webinar Registration
  • Thursday, September 22; 1:30 – 3:00 PM EST
    Diving Deeper into the New NIH Data Management and Sharing Policy
    In this second webinar of the series, we will expand upon the information presented in the first webinar and dive deeper into topics including privacy protections for data from human participants and justifiable limitations on sharing data.
    September 22 – Part 2 – DMS Webinar Registration

These webinars will be recorded and made available for on-demand viewing after the event.




Know Your Closeout Obligations at Project’s End

Within 120 days of your project period’s end date, you must submit the following Final Reports for Grant Closeout:

  • Final Research Performance Progress Report (F-RPPR)
  • Final Federal Financial Report (FFR)
  • Final Invention Statement and Certification (FIS)




ASTRO is now accepting applications for the 2022 Health Policy Fellowship. The Health Policy Fellowship is designed to provide exposure to ASTRO’s health policy reimbursement and coding activities and to develop the next generation of ASTRO health policy leaders. Health Policy Fellows will gain experience and knowledge in radiation oncology code development and valuation, coding guidance, payer engagement and payment reform activities. ASTRO members who are board-certified radiation oncologists or medical physicists with at least five years of experience are encouraged to apply.

Applications are due September 2, 2022. To learn about the fellowship program structure, applicant eligibility and selection criteria, please review the fellowship application and  fellowship fact sheet, and register to attend an informational webinar to hear from former HP Fellows on June 1, 8:00-9:00 p.m. Eastern time. Email your application documents or any fellowship inquiries to ASTRO’s Senior Manager of Health Policy



The RRS Annual Meeting, to be held October 16-19, 2022 at the Hilton Waikoloa Village,  offers an important and unique opportunity for radiation researchers from the disciplines of physics, chemistry, biology, epidemiology and medicine to discuss their new ideas and findings, in a relaxing and beautiful atmosphere that will stimulate new research and fresh collaborations, so enhancing the multidisciplinary objectives of the RRS.  Registration is OPEN.




  • Notice of Special Interest (NOSI): Studies of Cellular/Molecular Pathobiological Mechanisms of Lung Diseases Using Human 3-Dimensional Cellular Systems (R01). (NOT-HL-22-030) NHLBI. The purpose of this NOSI is to promote research characterizing the pathobiological processes and mechanisms that drive the onset and progression of lung diseases at a molecular/cellular level, providing a systems-level understanding by studying experimental systems with cellular heterogeneity and 3-D architecture. It is expected that projects supported by this NOSI will utilize ex vivo preparations (e.g., thin human lung slices) or 3-D multi-cellular in vitro systems (e.g., organoids) of human lung cells and will employ state-of-art multi-omics measures (e.g., spatial or single cell/nucleus omics) to better understand specific pathobiological processes in systems of interacting cell types.


  • CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed). PAR-22-209. This Funding Opportunity Announcement (FOA) solicits applications for the early-stage development of therapeutics to mitigate the adverse health effects resulting from toxic chemical exposure. Chemical threats are toxic compounds that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include specific chemical warfare agents, toxic industrial chemicals, pesticides, and pharmaceutical-based agents. The overall scope of this solicitation includes validation of therapeutic targets and preclinical characterization of lead compounds. The UG3 phase of this FOA supports target validation and characterization of initial lead compound(s); UH3 phase activities include candidate optimization and in vivo demonstration of activity and efficacy in relevant post-exposure models. At the conclusion of the overall UG3/UH3 funding period, projects are expected to deliver at least one well-characterized therapeutic candidate.


The purpose of this Request for Information (RFI) is to solicit ideas for potential NIH Common Fund programs.


Don't forget: Call for Abstracts is open for the #ASTRO22 Annual Meeting and we invite you to submit abstracts from all aspects of oncology, #RadOnc and radiation therapy for non-oncologic conditions. View the abstract guidelines and submit by March 1.



Review: “Medical management of acute radiation syndrome”

Drs. Nicholas Dainiak and Joseph Albanese review recommendations from evidence-based and narrative reviews by expert consultants to the World Health Organization (WHO), a subsequent review of published hematopoietic syndrome (HS) cases, and guidelines for management of acute radiation syndrome. [Published 19 July 2022 • © 2022 Society for Radiological Protection.]


Nicholas Dainiak and Joseph Albanese


Read more:

“Medical management of acute radiation syndrome”



Job Opportunities



More Content via the CMRC Website:


SEND US your publications, events, news, and announcements.